Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study

被引:0
|
作者
Ronald E. Myers
Amy E. Leader
Jean Hoffman Censits
Edouard J. Trabulsi
Scott W. Keith
Anett M. Petrich
Anna M. Quinn
Robert B. Den
Mark D. Hurwitz
Costas D. Lallas
Sarah E. Hegarty
Adam P. Dicker
Charnita M. Zeigler-Johnson
Veda N. Giri
Hasan Ayaz
Leonard G. Gomella
机构
[1] Sidney Kimmel Medical College,Division of Population Science, Department of Medical Oncology
[2] Thomas Jefferson University,Department of Urology
[3] Sidney Kimmel Medical College,Department of Pharmacology and Experimental Therapeutics
[4] Thomas Jefferson University,Department of Radiation Oncology
[5] Sidney Kimmel Medical College,School of Biomedical Engineering, Science and Health Systems
[6] Thomas Jefferson University,undefined
[7] Sidney Kimmel Medical College,undefined
[8] Thomas Jefferson University,undefined
[9] Drexel University,undefined
来源
Journal of Cancer Education | 2018年 / 33卷
关键词
Prostate cancer; Active surveillance; Shared decision making; Decision support interventions;
D O I
暂无
中图分类号
学科分类号
摘要
This study aimed to explore the effects of a decision support intervention (DSI) and shared decision making (SDM) on knowledge, perceptions about treatment, and treatment choice among men diagnosed with localized low-risk prostate cancer (PCa). At a multidisciplinary clinic visit, 30 consenting men with localized low-risk PCa completed a baseline survey, had a nurse-mediated online DS session to clarify preference for active surveillance (AS) or active treatment (AT), and met with clinicians for SDM. Participants also completed a follow-up survey at 30 days. We assessed change in treatment knowledge, decisional conflict, and perceptions and identified predictors of AS. At follow-up, participants exhibited increased knowledge (p < 0.001), decreased decisional conflict (p < 0.001), and more favorable perceptions of AS (p = 0.001). Furthermore, 25 of the 30 participants (83 %) initiated AS. Increased family and clinician support predicted this choice (p < 0.001). DSI/SDM prepared patients to make an informed decision. Perceived support of the decision facilitated patient choice of AS.
引用
收藏
页码:180 / 185
页数:5
相关论文
共 50 条
  • [41] Variation in the use of active surveillance for low-risk prostate cancer
    Loeppenberg, Bjoern
    Friedlander, David F.
    Krasnova, Anna
    Tam, Andrew
    Leow, Jeffrey J.
    Nguyen, Paul L.
    Barry, Hawa
    Lipsitz, Stuart R.
    Menon, Mani
    Abdollah, Firas
    Sammon, Jesse D.
    Sun, Maxine
    Choueiri, Toni K.
    Kibel, Adam S.
    Quoc-Dien Trinh
    CANCER, 2018, 124 (01) : 55 - 64
  • [42] African American Men With Low-Risk Prostate Cancer Are Candidates for Active Surveillance: The Will-Rogers Effect?
    Qi, Robert
    Moul, Judd
    AMERICAN JOURNAL OF MENS HEALTH, 2017, 11 (06) : 1765 - 1771
  • [43] Currently Used Criteria for Active Surveillance in Men With Low-risk Prostate Cancer An Analysis of Pathologic Features
    Suardi, Nazareno
    Capitanio, Umberto
    Chun, Felix K. H.
    Graefen, Markus
    Perrotte, Paul
    Schlomm, Thorsten
    Haese, Alexander
    Huland, Hartwig
    Erbersdobler, Andreas
    Montorsi, Francesco
    Karakiewicz, Pierre I.
    CANCER, 2008, 113 (08) : 2068 - 2072
  • [44] Active treatment in low-risk prostate cancer: a population-based study
    Roy, S.
    Hyndman, M. E.
    Danielson, B.
    Fairey, A.
    Lee-Ying, R.
    Cheung, W. Y.
    Afzal, A. R.
    Xu, Y.
    Abedin, T.
    Quon, H. C.
    CURRENT ONCOLOGY, 2019, 26 (04) : E535 - E540
  • [45] Physicians' Perceptions of Factors Influencing the Treatment Decision-making Process for Men With Low-risk Prostate Cancer
    Davis, Kimberly
    Bellini, Paula
    Hagerman, Charlotte
    Zinar, Riley
    Leigh, Daniel
    Hoffman, Richard
    Aaronson, David
    Van den Eeden, Stephen
    Philips, George
    Taylor, Kathryn
    UROLOGY, 2017, 107 : 86 - 94
  • [46] Multi-level Factors to Build Confidence and Support in Active Surveillance for Low-Risk Prostate Cancer: A Qualitative Study
    Chen, Jason C.
    Subramanian, Lalita
    Skolarus, Ted A.
    Hawley, Sarah T.
    Rankin, Aaron
    Fetters, Michael D.
    Witzke, Karla
    Borza, Tudor
    Radhakrishnan, Archana
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2025, : 1107 - 1115
  • [47] Active surveillance for low-risk prostate cancer: knowledge, acceptance and practice among urologists
    M A Gorin
    A Eldefrawy
    O Ekwenna
    M S Soloway
    Prostate Cancer and Prostatic Diseases, 2012, 15 : 177 - 181
  • [48] Active surveillance for low-risk prostate cancer: knowledge, acceptance and practice among urologists
    Gorin, M. A.
    Eldefrawy, A.
    Ekwenna, O.
    Soloway, M. S.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2012, 15 (02) : 177 - 181
  • [49] Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment
    Dall'Era, Marc A.
    Cowan, Janet E.
    Simko, Jeffrey
    Shinohara, Katsuto
    Davies, Benjamin
    Konety, Badrinath R.
    Meng, Maxwell V.
    Perez, Nannette
    Greene, Kirsten
    Carroll, Peter R.
    BJU INTERNATIONAL, 2011, 107 (08) : 1232 - 1237
  • [50] Can we expand the borders in active surveillance for low-risk prostate cancer?
    Islamoglu, Ekrem
    Kisa, Erdem
    Yucel, Cem
    Celik, Orcun
    Cakmak, Ozgur
    Yalbuzdag, Okan
    Kozacioglu, Zafer
    JOURNAL OF CLINICAL UROLOGY, 2019, 12 (01) : 54 - 59